BioSpace News Archive

Pharm Country

Schrödinger’s Financing Round Increases to $110 Million With New Investor Support

The financing is expected to be used to advance the company’s computational platform, as well as expand Schrödinger’s therapeutic pipeline.

May 21, 2019
·
2 min read
·
Alex Keown
Drug Development

Merck’s Keytruda Fails Triple-Negative Breast Cancer Trial

Merck & Co. announced that its Keytruda failed to hit its primary endpoint in the Phase III Keynote-119 clinical trial. The primary endpoint was superior overall survival compared to chemotherapy.

May 21, 2019
·
3 min read
·
Mark Terry
Deals

Amryt Acquires Aegerion to Expand its Rare Disease Portfolio

The deal gives Amryt a toehold in the United States with the previously approved Juxtapid, a treatment for the inherited cholesterol disorder homozygous familial hypercholesterolaemia.

May 21, 2019
·
2 min read
·
Alex Keown
Business

Alphabet’s Verily Inks Collaboration Deal with Big Pharma Companies and Health Systems

Verily announced a strategic collaboration deal with Novartis, Otsuka, Pfizer, Sanofi and six major health systems.

May 21, 2019
·
3 min read
·
Mark Terry
Job Trends

More Hacks Inevitable in Pharma Industry, Cybersecurity Expert Says

Andrew Douthwaite, chief technology officer for Colorado-based VirtualArmour, a cybersecurity company, told BioSpace that biotech and pharma companies are desirable targets for hackers and cyber thieves due to the value of the intellectual property.

May 21, 2019
·
3 min read
·
Alex Keown
IME Medical Electrospinning launches MediSpin XL, a cutting-edge high-volume electrospinning production platform for Medical Devices - 21 May 2019

Breakthrough in industrial large-scale manufacturing of well-defined biomedical fiber-based scaffolds for a wide variety of medical applications

May 21, 2019
·
5 min read
Deals

Promore Pharma AB (publ) Interim report January – March 2019

Promore Pharma’s most important task is to develop new products aiming to improve the quality of life for patients with difficult-to-treat wounds and various types of scarring, primarily following surgery.

May 21, 2019
·
3 min read
Heidelberg Pharma Reports Outcome Of Annual General Meeting

Heidelberg Pharma AG announced that the shareholders of the Company approved the resolutions of the administration with large majorities during the Annual General Meeting.

May 21, 2019
·
3 min read
Report from the Annual General Meeting of Promore Pharma AB held on 21 May 2019

Promore Pharma AB held its AGM on Tuesday, 21 May 2019.

May 21, 2019
·
3 min read
Drug Development

Boehringer Ingelheim Lands Positive Results in Lung Disease Trial

Germany-based Boehringer Ingelheim announced that its SENSCIS Phase III clinical trial met its primary endpoint, which was reduction in the annual rate of decline in forced vital capacity.

May 21, 2019
·
2 min read
·
Mark Terry